Laurus Labs Limited Asset Resilience Ratio

Latest as of September 2025: 0.74%

Laurus Labs Limited asset resilience ratio. Laurus Labs Limited (LAURUSLABS) has an Asset Resilience Ratio of 0.74% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Laurus Labs Limited (LAURUSLABS) liquidity interval to measure how many days the company can operate on defensive assets alone.

Liquid Assets

Rs697.20 Million

≈ $7.54 Million USD Cash + Short-term Investments

Total Assets

Rs94.15 Billion

≈ $1.02 Billion USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio of Laurus Labs Limited (2015–2025)

Asset resilience ratio of Laurus Labs Limited from 2015 to 2025. This chart shows how Laurus Labs Limited's Asset Resilience Ratio has changed over time. Read LAURUSLABS current and long-term liabilities for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Laurus Labs Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see LAURUSLABS asset base.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Rs633.80 Million	0.67%
Short-term Investments	Rs63.40 Million	0.07%
Total Liquid Assets	Rs697.20 Million	0.74%

Asset Resilience Insights

Limited Liquidity: Laurus Labs Limited maintains only 0.74% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Laurus Labs Limited Industry Peers by Asset Resilience Ratio

Compare Laurus Labs Limited's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Jiangsu Hengrui Medicine Co Ltd SHG:600276	Drug Manufacturers - Specialty & Generic	0.16%
Sandoz Group AG SW:SDZ	Drug Manufacturers - Specialty & Generic	7.89%
H Lundbeck A/S CO:HLUN-B	Drug Manufacturers - Specialty & Generic	-0.56%
Changchun High & New Technology Industries Group Inc SHE:000661	Drug Manufacturers - Specialty & Generic	5.50%
Hubei Jumpcan Pharmaceutical Co Ltd SHG:600566	Drug Manufacturers - Specialty & Generic	47.16%
Kangmei Pharmaceutical Co Ltd SHG:600518	Drug Manufacturers - Specialty & Generic	0.00%
Viyash Scientific Limited NSE:SEQUENT	Drug Manufacturers - Specialty & Generic	0.08%
Anhui Fengyuan Pharmaceutical Co Ltd SHE:000153	Drug Manufacturers - Specialty & Generic	1.81%

Laurus Labs Limited Asset Resilience Ratio by Year (2015–2025)

Laurus Labs Limited asset resilience ratio by year from 2015 to 2025. The table below shows the annual Asset Resilience Ratio data for Laurus Labs Limited.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-03-31	0.57%	Rs528.20 Million ≈ $5.71 Million	Rs93.36 Billion ≈ $1.01 Billion	+0.33pp
2024-03-31	0.23%	Rs195.50 Million ≈ $2.11 Million	Rs83.87 Billion ≈ $907.03 Million	-0.15pp
2023-03-31	0.38%	Rs294.00 Million ≈ $3.18 Million	Rs76.60 Billion ≈ $828.44 Million	+0.06pp
2022-03-31	0.32%	Rs222.40 Million ≈ $2.41 Million	Rs69.68 Billion ≈ $753.57 Million	-0.36pp
2021-03-31	0.68%	Rs390.70 Million ≈ $4.23 Million	Rs57.51 Billion ≈ $621.92 Million	+0.68pp
2020-03-31	0.00%	Rs880.00K ≈ $9.52K	Rs37.50 Billion ≈ $405.58 Million	+0.00pp
2019-03-31	0.00%	Rs740.00K ≈ $8.00K	Rs33.31 Billion ≈ $360.26 Million	+2.21pp
2018-03-31	-2.20%	Rs-664.70 Million ≈ $-7.19 Million	Rs30.17 Billion ≈ $326.25 Million	+0.24pp
2017-03-31	-2.44%	Rs-648.62 Million ≈ $-7.01 Million	Rs26.53 Billion ≈ $286.96 Million	-2.09pp
2016-03-31	-0.35%	Rs-81.68 Million ≈ $-883.34K	Rs23.03 Billion ≈ $249.07 Million	+3.48pp
2015-03-31	-3.84%	Rs-706.89 Million ≈ $-7.64 Million	Rs18.43 Billion ≈ $199.28 Million	--

pp = percentage points

About Laurus Labs Limited

NSE:LAURUSLABS India Drug Manufacturers - Specialty & Generic

Market Cap

$13.58 Billion

Rs1.26 Trillion INR

Market Cap Rank

#1730 Global

#60 in India

Share Price

Rs2323.80

Change (1 day)

+0.03%

52-Week Range

Rs944.90 - Rs2405.50

All Time High

Rs2405.50